Brainsway Ltd. BWAY 深 滬
已收盤 02-06 16:00:00 美东时间
21.78
+0.850
+4.06%
華盛通- 最 高21.95
- 今 開21.29
- 成交量 3.20万股
- 最 低 20.96
- 昨 收 20.93
- 總市值 4.27亿
- 52周最高 25.65
- 市盈率 靜 195.69
- 換手率 0.16%
- 52周最低 7.84
- 委 比 95.24%
- 總股本 1960.82万
- 歷史最高 25.65
- 量 比 0.34
- 振 幅 4.73%
- 歷史最低 1.38
- 每 手 1
- 風險率 4.18%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | 斯伦贝谢、SouthState Bank、西屋制动、特里科银行获多家大行上调目标价；苹果、meta、微软等绩前遭下调目标价
今日重点评级关注：Oppenheimer：维持Pelthos Therapeutics"跑赢大市"评级，目标价从57美元升至60美元；Small Cap Consumer Research：维持Lands' End"买入"评级，目标价从20美元升至45美元
01-27 10:02
Meta To Rally More Than 36%? Here Are 10 Top Analyst Forecasts For Monday
Top Wall Street analysts changed their outlook on these top names. For a comple...
01-26 21:35
HC Wainwright & Co. Maintains Buy on BrainsWay, Raises Price Target to $30
HC Wainwright & Co. analyst Raghuram Selvaraju maintains BrainsWay (NASDAQ:BWAY) with a Buy and raises the price target from $24 to $30.
01-26 19:54
BrainsWay Announces Premera Blue Cross Blue Shield Adopts New Final Medical Policy To Treat Moderate To Severe Major Depressive Disorder With Brainsway's Accelerated SWIFT Deep TMS Protocol
BrainsWay Ltd. (NASDAQ & TASE: BWAY) ("BrainsWay" or the "Company"), a global leader in advanced noninvasive brain stimulation technologies, today announced that Premera Blue Cross Blue Shield®, a company with
01-07 20:38
BrainsWay Secures Optum Coverage Expansion For Deep TMS In Adolescent Depression
BrainsWay Ltd. (NASDAQ & TASE: BWAY) ("BrainsWay" or the "Company"), a global leader in advanced noninvasive brain stimulation technologies, today announced that Optum Behavioral Health, a leading health services
2025-12-22 20:43
美股大行评级 | 潜在涨幅2566.67%！Ascendiant Capital上调GRI Bio目标价至36美元，维持"买入"评级
今日重点评级关注：Ascendiant Capital：维持GRI Bio"买入"评级，目标价从35美元升至36美元；Ascendiant Capital：维持Atossa Therapeutics"买入"评级，目标价从7.75美元升至8美元
2025-12-09 10:32
HC Wainwright & Co. Maintains Buy on BrainsWay, Raises Price Target to $24
HC Wainwright & Co. analyst Raghuram Selvaraju maintains BrainsWay (NASDAQ:BWAY) with a Buy and raises the price target from $18 to $24.
2025-12-08 20:37
BrainsWay Initiates Clinical Trial for Alcohol Use Disorder
Brainsway ( ($BWAY) ) has shared an announcement. On November 17, 2025, BrainsW...
2025-11-17 20:58
美股大行评级 | 思科、On Holding、派拓网络等获多家机构上调目标价；Circle 遭富国、德银等多家机构下调目标价
今日重点评级关注：HC Wainwright & Co.：维持PDS Biotechnology"买入"评级，目标价从13美元升至15美元；HC Wainwright & Co.：维持PepGen Inc."买入"评级，目标价从18美元升至20美元
2025-11-14 10:43
美股大行评级 | 富国银行上调AMD目标价升至345美元；花旗上调礼来目标价升至1500美元；巴克莱上调腾讯音乐目标价升至28美元
今日重点评级关注：HC Wainwright & Co.：维持Artiva Biotherapeutics"买入"评级，目标价从12美元升至15美元；Canaccord Genuity：维持Viking Therapeutics"买入"评级，目标价从106美元升至107美元
2025-11-13 09:58
